Arrhythmia Research Technology (HRT) Widens Q2 Loss to 37c/Share
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Research and development: 24.53K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 24.53K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Arrhythmia Research Technology (AMEX: HRT) reported Q2 EPS of ($0.37), versus ($0.09) reported last year. Revenue for the quarter came in at $4.98 million, versus $6.02 million reported last year.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Optimum Communications gets NYSE non-compliance notice over stock price
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
